Acute chest syndrome in the setting of SARS-COV-2 infections—A case series at an urban medical center in the Bronx

Research output: Contribution to journalArticle

Abstract

New York City has emerged as one of the epicenters of the SARS-COV-2 pandemic, with the Bronx being disproportionately affected. This novel coronavirus has caused significant respiratory manifestations raising the concern for development of acute chest syndrome (ACS) in patients with sickle cell disease (SCD). We report a series of pediatric SCD SARS-COV-2-positive patients admitted with ACS. SARS-COV-2-positive SCD patients, who did not develop ACS, were the comparison group. Hydroxyurea use (P-value =.02) and lower absolute monocyte counts (P-value =.04) were noted in patients who did not develop ACS. These preliminary findings need to be further evaluated in larger cohorts.

Original languageEnglish (US)
Article numbere28579
JournalPediatric Blood and Cancer
Volume67
Issue number11
DOIs
StateAccepted/In press - 2020

Keywords

  • COVID-19
  • hemoglobinopathies
  • infections in immunocompromised hosts
  • sickle cell disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Acute chest syndrome in the setting of SARS-COV-2 infections—A case series at an urban medical center in the Bronx'. Together they form a unique fingerprint.

  • Cite this